AI Article Synopsis
- Numerous studies confirm that stereotactic body radiation therapy (SBRT) is both effective and safe for treating prostate cancer.
- Managing prostate motion during treatment is crucial since SBRT relies on precise targeting.
- The case report discusses the first use of SBRT for prostate cancer with tomotherapy and real-time motion tracking using the Synchrony system.
Article Abstract
Numerous prospective and retrospective studies have demonstrated the efficacy and safety of stereotactic body radiation therapy (SBRT) for prostate cancer. Since SBRT utilizes a very tight margin, management of intrafraction prostate motion is necessary. As a real-time motion tracking and correction system (Synchrony; Accuray, Sunnyvale, CA) has been introduced in the newer platform of tomotherapy (Radixact; Accuray), Radixact can deliver tracking SBRT. In the case report, we present the first clinical experience with prostate SBRT using tomotherapy with Synchrony fiducial tracking.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362472 | PMC |
| http://dx.doi.org/10.7759/cureus.40778 | DOI Listing |
Publication Analysis
Top Keywords
stereotactic body
8
body radiation
8
radiation therapy
8
prostate cancer
8
tomotherapy synchrony
8
synchrony fiducial
8
fiducial tracking
8
prostate
4
therapy prostate
4
cancer tomotherapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!